Supplies of high-demand obesity treatments are improving, but that doesn’t mean it's easier to get them. Many employers and ...
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound ... due to the weight loss, but a recent ...
Senators questioned Novo Nordisk CEO Lars Jørgensen on Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, which are cheaper in other countries. The CEO of ...
Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback